Unleash your ultimate sequencing speed
As one of the sequencers with the fastest speed among mid-low throughput in the world, DNBSEQ-G99 is developed based on MGI’s core DNBSEQ sequencing technology, enabled by innovations in biochemistry, optics, fluidics, temperature control, and other core systems. DNBSEQ-G99 is applicable for multiple sequencing methods and only needs 12 hours to complete PE150 sequencing.
Benchtop Genetic Sequencer DNBSEQ-G99
UNLEASH YOUR ULTIMATE SEQUENCING SPEED
- DNBSEQ-G99 is developed based on MGI’s core DNBSEQ™ sequencing technology, Enabled by innovations in biochemistry, optics, fluidics, temperature control, and other core systems, DNBSEQ-G99 boasts the fastest speed amongst all medium-to-low throughput sequencers globally.
- DNBSEQ-G99 is especially applicable for targeted oncology panel sequencing, infectious disease sequencing, oncology methylation sequencing, small whole-genome sequencing, low-depth whole genome sequencing, individual identification, small panel sequencing of 24-28 samples, or whole-exome sequencing of 1-4 samples.
Rapid sequencing
Flexible throughput
Bioinformatics integrated
- Only 12 hrs for PE150 (from loading to FASTQ).
Flexible throughput
- Independent loading and running of dual flow cells.
Bioinformatics integrated
- Option to include built-in bioinformatics module to support sequencing and advanced analysis in a single machine.
Superior Performance
Available Models
DNBSEQ-G99RS
DNBSEQ-G99 delivers uncompromised high data quality. A multitude of applications can be executed on DNBSEQ-G99, such as targeted sequencing, small genome and Low pass WGS WGS sequencing, etc.
In addition, DNBSEQ-G99ARS supports the retrieval of data at intermediate time points under the Bioanalysis by Sequencing (BBS) mode. Users can obtain the first batch of summary report as quick as 2.5 hrs from the start of sequencing run (read length: SE40).
In addition, DNBSEQ-G99ARS supports the retrieval of data at intermediate time points under the Bioanalysis by Sequencing (BBS) mode. Users can obtain the first batch of summary report as quick as 2.5 hrs from the start of sequencing run (read length: SE40).
DNBSEQ-G99ARS
Configuration 1:
Without Bioinformatics module
Without Bioinformatics module
Configuration 2:
With Bioinformatics module
With Bioinformatics module
Specification
Read Length: PE150≤12h
SE100≤5h
SE100≤5h
Novel Reagent Cartridge Design
- Pre-loaded reagents within cartridge, one-step operation: simply press to load
- Sequencing and cleaning cartridges combined 2-in-1, cleaning initiates automatically after run.
Flow cells:
Dual flow cell system
Effective reads:
80 M (1 Lanes per flow cell)
Dual flow cell system
Effective reads:
80 M (1 Lanes per flow cell)
Output:
8~48GB per run
8~48GB per run
Learn more about MGI Patented DNBSEQ™ Technology – Enhancing Accuracy
DNBSEQ™ provides the advantages of low amplification error rate from DNBs and high-density Patterned Arrays to significantly improve the accuracy of sequencing with a low repetition rate.
Combined with the PCR-free library preparation approach, it reduces the error of entry during amplification and greatly improves the accuracy of detecting SNPs and indels.
DNBSEQ™ provides the advantages of low amplification error rate from DNBs and high-density Patterned Arrays to significantly improve the accuracy of sequencing with a low repetition rate.
Combined with the PCR-free library preparation approach, it reduces the error of entry during amplification and greatly improves the accuracy of detecting SNPs and indels.
Want to know more about our special promo?
Reach out to us
By clicking the button you agree to our Privacy Policy
DNBSEQ-G99 is the only medium-to-low throughput sequencer with a dual flow cell loading configuration, providing ultimate flexibility in sequencing throughput. The dual flow cells can be operated with different read lengths independently or concurrently. Three flow cell loading modes are supported on DNBSEQ-G99: Single, Dual concurrent, or Dual independent, Laboratory technicians can decide number of flow cells to operate in accordance with the sample size and requirements.
About MGI
MGI is a leading producer of clinical high-throughput gene sequencers and automation platforms with a vision to lead life science through Intelligent innovation.
Founded in 2016, MGI has more than 1800 employees, nearly half of whom are R&D personnel. MGI operates in more than 80 countries and regions and has established multiple research and production bases around the world. Providing real-time, comprehensive, life-long solutions, its vision is to enable effective and affordable healthcare packages for all.
Aligned with MGI's mission to develop and promote advanced life science tools for future healthcare across Europe and Africa, MGI has launched Customer Experience Centers to enable customers and partners to build new scientific workflows and to amplify knowledge while further developing relevant capabilities and expertise.
